Research Nester published a report titled “High-Throughput Screening (HTS) Market: Global Demand Analysis & Opportunity Outlook 2030” which delivers detailed overview of the global high-throughput screening (HTS) market in terms of market segmentation by products & services, technology, application, end-user, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global high-throughput screening (HTS) market is anticipated to grow with a CAGR of 8.4% during the forecast period, i.e., 2021-2030. The market is segmented by products & services into consumables, instruments, software, and services, out of which, the consumables segment is projected to grow with the highest CAGR of 8.6% during the forecast period, and further touch a revenue of USD 15676.79 Million by the end of 2030, up from USD 6937.73 Million in the year 2020.
The global high-throughput screening (HTS) market is estimated to garner a revenue of USD 36227.8 Million by the end of 2030, up from a revenue of USD 16294.7 Million in the year 2020. Rising concern for the prevalence of chronic diseases worldwide, followed by the increasing healthcare expenditure, and the growing focus of pharmaceutical and biotechnology companies to develop advanced medicines, are some of the major factors anticipated to drive the market growth.
The global high-throughput screening market is segmented on the basis of geographical analysis into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region, out of which, the market in the North America is expected to hold the highest market share during the forecast period and further attain the largest revenue of USD 15722.9 Million by the end of 2030. The market in the region is further segmented by country into the U.S., and Canada, out of which, the market in the U.S. is expected to hold the highest market share and further grow with the highest CAGR of 8.6% during the forecast period.
The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.
Growing Focus of Governments for R&D in the Field of Biotechnology
In one of the statistics by the National Institute of Health (NIH), in the year 2020, research funding in the field of biotechnology in the United States, touched USD 7767 Million, up from USD 5698 Million in the year 2013.
Owing to the growing prevalence of chronic diseases worldwide, the government of nations are increasingly focusing on raising their expenditure for the research and developments in the field of biotechnology and pharmaceutical sciences. The surge in medical research is therefore expected to drive the demand for high-throughput screening, and in turn drive the market growth.
However, the complexities in the development of assays is expected to operate as key restraint to the growth of global high-throughput screening (HTS) market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the global high-throughput screening (HTS) market which includes company profiling of Agilent Technologies, Inc., Thermo Fisher Scientific, Tecan Trading AG, Promega Corporation, Hamilton Company, BPS Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Carna Biosciences, Inc., Danaher Corporation, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global high-throughput screening (HTS) market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.